Citius Oncology
Yahoo Finance • last month
Citius Oncology deploys AI platform to support LYMPHIR launch
NEW JERSEY - Citius Oncology, Inc. (NASDAQ:CTOR) has implemented an artificial intelligence platform to enhance its commercial operations ahead of the anticipated launch of LYMPHIR, a treatment for cutaneous T-cell lymphoma (CTCL), the com... Full story
Yahoo Finance • 2 months ago
Citius Oncology Beats Fiscal Q3 EPS
Key Points GAAP loss per share of ($0.08) for Q3 FY2025 beat analyst expectations by $0.07 No revenue was reported for Q3 FY2025, as LYMPHIR has not yet launched commercially.These 10 stocks could mint the next wave of millionaires › Cit... Full story
Yahoo Finance • 3 months ago
Catalyst Watch: Amazon Prime Day, Delta earnings and stock-by-stock trade deal implications
[Business and stock exchange data on the screen.] Torsten Asmus Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next... Full story
Yahoo Finance • 3 months ago
Catalyst Watch: Jobs Report, Tesla deliveries, Constellation Brands earnings, and Circle ratings
[Trading charts background] da-kuk/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MO... Full story
Yahoo Finance • 3 months ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.08%
Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Consumer Goods and Telecoms sectors led shares higher while losses in the Basic Materials, Technology and Healthcare sectors led shares lower. At... Full story
